Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Boris V. Janssen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5678-1510; OpenAlex author ID A5090080796. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
45
Papers, trials and grants by year

2021: 3 papers · 2022: 2 papers · 2023: 2 papers · 2024: 3 papers · 2025: 2 papers · 2026: 1 paper

Papers 13

  1. Response to 'Towards an individualized strategy in perioperative chemotherapy for pancreatic cancer'. Co-author DOI 10.1038/s41416-025-03294-w↗
  2. Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. Co-author DOI 10.1001/jamaoncol.2024.5917↗
  3. Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an interna… Co-author DOI 10.1038/s41416-025-03025-1↗
  4. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy. Co-author DOI 10.1001/jamanetworkopen.2024.17625↗
  5. Artificial Intelligence-based Segmentation of Residual Pancreatic Cancer in Resection Specimens Following Neoadjuvant Treatment (ISGPP-2): International Improv… Co-author DOI 10.1097/pas.0000000000002270↗
  6. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer. First author DOI 10.1186/s41747-023-00419-9↗
  7. Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival… Co-author DOI 10.1245/s10434-023-13465-9↗
  8. Computer-Aided Detection for Pancreatic Cancer Diagnosis: Radiological Challenges and Future Directions. Co-author DOI 10.3390/jcm12134209↗
  9. Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1). Co-author DOI 10.1093/bjs/znac350↗
  10. Imaging-based Machine-learning Models to Predict Clinical Outcomes and Identify Biomarkers in Pancreatic Cancer: A Scoping Review. Co-author DOI 10.1097/sla.0000000000005349↗
  11. Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy. Co-author DOI 10.1038/s41379-020-00683-9↗
  12. Scoring of tumour response after neoadjuvant therapy in resected pancreatic cancer: systematic review. First author DOI 10.1093/bjs/znaa031↗
  13. Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant Treatment. Co-author DOI 10.3390/cancers13205089↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc G. Besselink · 9 shared papers, 2021–2024 · strength 1.25
  2. Joanne Verheij · 6 shared papers, 2021–2024 · strength 0.73
  3. Geert Kazemier M · 4 shared papers, 2021–2024 · strength 0.62
  4. Caroline Sophie Verbeke · 4 shared papers, 2021–2024 · strength 0.48
  5. Lodewijk A.A. Brosens · 4 shared papers, 2021–2023 · strength 0.47
  6. Stijn R. van Roessel · 4 shared papers, 2021–2022 · strength 0.44
  7. Olca Baştürk · 3 shared papers, 2021–2024 · strength 0.34
  8. Volkan N. Adsay · 3 shared papers, 2021–2024 · strength 0.34
  9. Huamin Wang · 3 shared papers, 2021–2024 · strength 0.34
  10. Seung‐Mo Hong · 3 shared papers, 2021–2024 · strength 0.34
  11. Anthony James Gill · 3 shared papers, 2021–2024 · strength 0.34
  12. Iréne Esposito · 3 shared papers, 2021–2024 · strength 0.34
  13. Claudio Luchini · 3 shared papers, 2021–2022 · strength 0.33
  14. Angela S. Y. Chou · 2 shared papers, 2022–2024 · strength 0.25
  15. Deyali Chatterjee · 2 shared papers, 2022–2024 · strength 0.25
  16. Bas Groot Koerkamp · 2 shared papers, 2021–2023 · strength 0.23
  17. Eline C. Soer · 2 shared papers, 2021 · strength 0.22
  18. Johanna W. Wilmink · 2 shared papers, 2021 · strength 0.20
  19. Jacqueline Isabel Bereska · 1 shared paper, 2024 · strength 0.20
  20. Inez M. Verpalen · 1 shared paper, 2024 · strength 0.20
  21. Chanjuan Shi · 2 shared papers, 2021–2022 · strength 0.19
  22. Noriyoshi Fukushima · 2 shared papers, 2021–2022 · strength 0.19
  23. Claudio Doglioni · 2 shared papers, 2021–2022 · strength 0.19
  24. Ralph H. Hruban MD · 2 shared papers, 2021–2022 · strength 0.19
  25. Aatur Dilip Singhi · 2 shared papers, 2021–2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.